Get the Stockscreener App
30.37
1.81%
0.54
After Hours:
30.37
Omnicell Inc stock is traded at $30.37, with a volume of 739.72K.
It is up +1.81% in the last 24 hours and down -2.85% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$29.83
Open:
$29.58
24h Volume:
739.72K
Relative Volume:
1.10
Market Cap:
$1.42B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-66.02
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
+7.58%
1M Performance:
-2.85%
6M Performance:
-34.81%
1Y Performance:
-6.98%
1-Day Range:
$29.32
$30.51
1-Week Range:
$28.62
$30.51
52-Week Range:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
30.37 | 1.32B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
279.70 | 37.97B | 2.75B | 714.14M | 1.09B | 4.33 |
|
TEM
Tempus Ai Inc
|
55.18 | 10.83B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.61 | 8.58B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.09 | 9.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.98 | 6.68B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Central Fill Pharmacy Automation Market Top Companies Study -Omnicell, Inc., McKesson Corporation, ScriptPro LLC - openPR.com
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
Omnicell, Inc. authorizes a Buyback Plan. - marketscreener.com
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stock Jumps 5.9% on Strong Profit Guidance and China Tariff CutsNews and Statistics - IndexBox
BofA lifts Omnicell stock price target to $34 from $30 - Investing.com Australia
BofA lifts Omnicell stock price target to $34 from $30 By Investing.com - Investing.com Nigeria
Why Omnicell (OMCL) Stock Is Trading Up Today - Yahoo Finance
Omnicell upgraded at Wells Fargo on positive risk-reward setup - MSN
Omnicell Inc (OMCL) Shares Down 3.27% on May 21 - GuruFocus
Omnicell (OMCL) Adjusts Q2 Revenue and EBITDA Guidance | OMCL St - GuruFocus
Omnicell Updates Q2, 2025 Earnings Guidance, Approves New $75 Million Share Buyback Plan - marketscreener.com
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Pla - GuruFocus
Omnicell (OMCL) Board Approves New $75 Million Stock Buyback Plan | OMCL Stock News - GuruFocus
Omnicell (OMCL) Updates FY25 Outlook Amid Tariff Reductions | OM - GuruFocus
Omnicell Updates 2025 Guidance and Stock Buyback Plan - TipRanks
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program - BioSpace
Omnicell Expects Improved Profitability, Updates Second Quarter - GuruFocus
Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program | OMCL Stock News - GuruFocus
How the Pharmacy Automation Market Will Evolve by 2032Growth, - openPR.com
Omnicell Surpasses Q1 2025 Revenue Expectations Amidst Future ChallengesNews and Statistics - IndexBox
OMCL Q1 Earnings Call: Revenue Tops Expectations but Tariff Headwinds Pressure Profit Outlook - Yahoo Finance
Omnicell opens innovation lab in Texas - MSN
Omnicell launches RFID products for medication management - Investing.com Australia
Omnicell (OMCL) Unveils New Solutions to Optimize Healthcare Wor - GuruFocus
Omnicell's New Perioperative Clinic Setting Products May Boost Stock - Yahoo Finance
AI companies target Central Texas in latest tech scene shakeup - MySA
Omnicell launches RFID products for medication management By Investing.com - Investing.com Nigeria
3 Hated Stocks Skating on Thin Ice - Yahoo Finance
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omnicell Inc Stock (OMCL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
0.25%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):